Program directory · Canadian Nuclear Safety Commission
Nuclear Substances and Prescribed Equipment Program
- Department
- Canadian Nuclear Safety Commission
- Program code
- BTJ03 (AECB)
- Core responsibility
- Nuclear Regulation
- In Departmental Plans
- 2018-19 – 2026-27 · New since an earlier plan
What it does
This program ensures the safe and secure use of nuclear substances and prescribed equipment in Canada to protect the health, safety and security of Canadians and the environment. The nuclear substances and prescribed equipment program includes oversight of nuclear substances and prescribed equipment in medical, industrial, academic/research and commercial sectors, and of dosimetry service providers, as well as the safe transport of nuclear substances. While the onus of safety is on the licensee, staff evaluate safety and security performance through inspections, event reviews, assessments, and reviews of licensee programs and processes. Licensing, compliance and certification activities are managed through a risk-informed approach. These activities include licensing the possession and use of nuclear substances and the delivery of dosimetry services; making recommendations to the Commission for licensing decisions on Class IB facilities; certifying transport packages, radiation devices, Class II prescribed equipment and radiation safety officers for Class II nuclear facilities; establishing compliance verification plans based on a risk-informed regulatory oversight model, taking into account licensee performance; and acting as technical specialists to other programs. The results of regulatory activities associated with this program are communicated annually to the public and other stakeholders. Outreach and communication with licensees is an ongoing process.
Source: the department's Program Inventory, via GC InfoBase.
History and lineage
First appears in GC InfoBase's actual spending by program in 2018-19. The data does not record when a program was created; it may be older than its first appearance here, which is limited by the sources (program spending starts in 2010-11, Departmental Plans in 2018-19).
| Program | Relation | Years with data | Actual spending over those years |
|---|---|---|---|
| Nuclear Substances and Prescribed Equipment Program | This program | 2018-19 – 2028-29 | $89.4M |
No earlier or later program in the same department has a similar name.
Significant changes in scope and budget
Detected from the data: renames between plans, programs it appears to replace, merge with or split into (matched by name), year-over-year changes in spending of at least 25% and $5M, or in employees of at least 20% and 25 FTEs, linked budget measures, and results indicators added or dropped.
No significant changes detected.
Success criteria
The program's indicators from its department's Departmental Results Framework: the target set in each year's plan, and the result reported the following year. Source: GC InfoBase.
Historical: targets against results
Bars: result reported. Dashed line: target.
| Report year | Target | Due | Result | Status |
|---|---|---|---|---|
| 2018-19 | ≥ 90% | 2019 | 99.6% | Met |
| 2019-20 | ≥ 90% | 2020 | 99.5% | Met |
| 2020-21 | ≥ 90% | 2021 | 95% | Met |
| 2021-22 | ≥ 90% | 2022 | 94% | Met |
| 2022-23 | ≥ 90% | 2023 | 94% | Met |
| 2023-24 | ≥ 90% | 2024 | 94% | Met |
| 2024-25 | ≥ 90% | 2025 | 94.6% | Met |
Current: the 2026-27 plan's targets
Bars: result reported. Dashed line: target.
| Report year | Target | Due | Result | Status |
|---|---|---|---|---|
| 2026-27 | ≥ 90% | 2027 | — | Planned |
Future goals: targets due after 2026-27
No targets with a later due date.
Spending and employees: planned against actual
Spending
Show the numbers
| Fiscal year | Planned | Actual |
|---|---|---|
| 2018-19 | $12.4M | $12.1M |
| 2019-20 | $13.4M | $12.4M |
| 2020-21 | $13.1M | $11.1M |
| 2021-22 | $12.7M | $11.6M |
| 2022-23 | $13.2M | $12.4M |
| 2023-24 | $13.4M | $13.2M |
| 2024-25 | $14.6M | $16.7M |
| 2025-26 | $17M | — |
| 2026-27 | $16.8M | — |
| 2027-28 | $17M* | — |
| 2028-29 | $16.8M* | — |
Employees (FTEs)
Show the numbers
| Fiscal year | Planned | Actual |
|---|---|---|
| 2018-19 | 84 | 85 |
| 2019-20 | 89 | 81 |
| 2020-21 | 88 | 77 |
| 2021-22 | 86 | 79 |
| 2022-23 | 82 | 78 |
| 2023-24 | 88 | 85 |
| 2024-25 | 86 | 91 |
| 2025-26 | 84 | — |
| 2026-27 | 89 | — |
| 2027-28 | 91* | — |
| 2028-29 | 91* | — |
Planned spending, plan by plan
Each row is one year's Departmental Plan and its forecast for the next three fiscal years; read a column down to see how the forecast for one year changed. The last row is what was actually spent. Click an amount for its source. Biggest changes in federal spending plans
| Plan | 2018-19 | 2019-20 | 2020-21 | 2021-22 | 2022-23 | 2023-24 | 2024-25 | 2025-26 | 2026-27 | 2027-28 | 2028-29 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-19 plan | $12,446,898 | $12,898,452 | $13,186,150 | ||||||||
| 2019-20 plan | $13,423,962 | $13,600,378 | $13,808,070 | ||||||||
| 2020-21 plan | $13,115,235 | $13,303,367 | $13,484,785 | ||||||||
| 2021-22 plan | $12,683,171 | $12,996,185 | $13,217,634 | ||||||||
| 2022-23 plan | $13,201,262 | $13,287,300 | $13,455,128 | ||||||||
| 2023-24 plan | $13,378,034 | $13,476,200 | $13,649,695 | ||||||||
| 2024-25 plan | $14,599,653 | $14,680,376 | $14,848,387 | ||||||||
| 2025-26 plan | $17,026,605 | $17,462,817 | $17,740,146 | ||||||||
| 2026-27 plan | $16,820,749 | $17,047,421 | $16,830,170 | ||||||||
| Actual | $12,050,934 | $12,380,838 | $11,142,050 | $11,558,332 | $12,351,562 | $13,176,113 | $16,699,263 |
Actual spending is from Departmental Results Reports and the Public Accounts, as published in GC InfoBase. FTEs are full-time equivalents.
